Electromed, Inc. (ELMD)
NYSEAMERICAN: ELMD · Real-Time Price · USD
23.86
+0.52 (2.23%)
At close: Mar 31, 2025, 4:00 PM
24.65
+0.79 (3.31%)
After-hours: Mar 31, 2025, 6:47 PM EST
Electromed Market Cap
Electromed has a market cap or net worth of $204.17 million as of April 1, 2025. Its market cap has increased by 43.58% in one year.
Market Cap
204.17M
Enterprise Value
188.04M
1-Year Change
43.58%
Ranking
Category
Stock Price
$23.86
Market Cap Chart
Since August 13, 2010, Electromed's market cap has increased from $32.60M to $204.17M, an increase of 526.28%. That is a compound annual growth rate of 13.35%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 31, 2025 | 204.20M | -18.29% |
Dec 31, 2024 | 249.90M | 166.99% |
Dec 29, 2023 | 93.60M | 5.17% |
Dec 30, 2022 | 89.00M | -20.11% |
Dec 31, 2021 | 111.40M | 31.99% |
Dec 31, 2020 | 84.40M | 15.46% |
Dec 31, 2019 | 73.10M | 72.00% |
Dec 31, 2018 | 42.50M | -15.17% |
Dec 29, 2017 | 50.10M | 57.05% |
Dec 30, 2016 | 31.90M | 105.81% |
Dec 31, 2015 | 15.50M | -28.24% |
Dec 31, 2014 | 21.60M | -21.74% |
Dec 31, 2013 | 27.60M | 150.91% |
Dec 31, 2012 | 11.00M | -60.57% |
Dec 30, 2011 | 27.90M | -2.79% |
Dec 31, 2010 | 28.70M | -11.96% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 738.61B |
UnitedHealth Group | 472.03B |
Johnson & Johnson | 394.52B |
AbbVie | 363.15B |
Novo Nordisk | 305.46B |
AstraZeneca | 229.16B |
Abbott Laboratories | 226.88B |
Merck & Co. | 225.40B |